[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"complex-coronary-artery-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:complex-coronary-artery-disease":67},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100608530",false,"NCT07202754","Procedural Complications and Long-Term Mortality in Complex Coronary Interventions","The Impact of Procedural Complications on Long-Term Mortality in Complex Coronary Interventions: The Multicenter COMPLEX-ANATOLIA Study","Inclusion Criteria:\n\n* Patients with complex coronary disease\n* Aged 18-85 years\n\nExclusion Criteria:\n\n* Patients diagnosed with cardiogenic shock\n* Coronary lesions with non-complex features\n* Percutaneous coronary intervention with a bare metal stent\n* Patient life expectancy \\\u003C1 year\n* Known relevant allergies\n* Absence of all medical records\n* Patients with early discontinuation of dual antiplatelet therapy","ALL","18 Years","85 Years",{"count":19,"type":20},20000,"ESTIMATED","OBSERVATIONAL","The relative risks for different non-fatal intraprocedural complications during complex percutaneous coronary intervention (PCI) on subsequent mortality have not been described. This study aimed to assess the association between non-fatal intraprocedural complications and late mortality after complex coronary PCI.",[24],"Complex Coronary Artery Disease",[26],"Complications, death, major adverse cardiac events, target vessel revascularization","NOT_YET_RECRUITING","2025-10-01",{"date":30,"type":31},"2025-10-02","ACTUAL",{"date":33,"type":20},"2025-11-01",{"date":35,"type":20},"2026-03-01",{"name":37,"class":38},"Istanbul Mehmet Akif Ersoy Educational and Training Hospital","OTHER_GOV",{"id":40,"slug":4,"hasResults":10,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":45,"targetDuration":47,"studyType":21,"phases":4,"briefSummary":48,"conditions":49,"keywords":52,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":4},"100564178","NCT06625801","IVUS CHIP UPP Registry","Intravascular Ultrasound Guidance for Complex High-risk Indicated Procedures in Underrepresented Patient Populations Registry","Inclusion Criteria:\n\n1. The patient must be ≥18 years of age and self-identify within a US census-defined minority\n2. Patients with an indication for PCI of at least one lesion satisfying any of the following criteria:\n\n   1. Angiographic heavy calcification\n   2. Ostial lesions\n   3. True bifurcation lesions involving side-branches \\>2.5mm\n   4. Left main lesions\n   5. Chronic total occlusion\n   6. In-stent restenosis\n   7. Long-lesions (estimated stent length \\> 28mm) OR Patient with an indication for PCI for any lesion and in need for elective mechanical circulatory support assisted PCI\n3. Presenting with silent ischemia, stable angina, unstable angina or non-ST-elevation acute coronary syndrome (NSTE-ACS)\n4. All lesions must be suitable for treatment with FDA-approved contemporary generation drug eluting stents or drug-coated balloons\n5. The patient is willing and able to cooperate with registry procedures and follow-up until registry completion\n6. Subject is able to confirm understanding of risks, benefits and treatment alternatives and he\u002Fshe (or an authorized legal representative) provides informed consent prior to any protocol-related procedure, as approved by the appropriate IRB\n\nExclusion Criteria:\n\n1. ST-elevation myocardial infarction or cardiogenic shock within prior 7 days\n2. Known untreated severe valvular heart disease\n3. Contraindication on the use of IVUS (i.e. extreme vessel tortuosity)\n4. Requiring PCI in a diseased aorto-coronary bypass\n5. Known contraindication or hypersensitivity to anticoagulants\n6. Absolute contraindications or allergy that cannot be pre-medicated, to iodinated contrast or to antiplatelet drugs, including both aspirin and P2Y12 inhibitors\n7. Non-cardiac co-morbidities with a life expectancy less than 1 year\n8. A patients that is currently participating in a clinical trial that has not yet reached its primary endpoint cannot be included in this registry. A patient may only be enrolled in this registry once.",{"count":46,"type":20},1010,"24 Months","The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.",[50,51,24],"Coronary Artery Disease","Coronary Artery Disease Risk High",[53,54,55,56],"PCI","intravascular ultrasound","CHIP","ivus-guidance","2025-08-25",{"date":59,"type":31},"2025-09-02",{"date":61,"type":20},"2025-09",{"date":63,"type":20},"2029-03",{"name":65,"class":66},"ECRI bv","INDUSTRY",""]